NSAIDs cut risk of pancreatitis post-ERCP
A one-off suppository dose of NSAIDs almost halves the risk of developing pancreatitis after endoscopic retrograde cholangiopancreatography, a randomised trial finds.
Just 9% of patients given rectal indomethacin immediately after the procedure went on to develop pancreatitis, compared with 17% of those given placebo, US researchers found.
They calculated that 13 people would need to be given the drug to prevent one episode of pancreatitis following endoscopic retrograde cholangiopancreatography (ERCP).
Moreover, the intervention reduced the